Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia

被引:8
|
作者
Tiis, Roza Pavlovna [1 ,2 ]
Osipova, Ludmila Pavlovna [1 ,2 ]
Lichman, Daria Veniaminovna [1 ,2 ]
Voronina, Elena Nikolaevna [2 ,3 ]
Filipenko, Maxim Leonidovich [2 ,3 ]
机构
[1] RAS, Inst Cytol & Genet, SB, Novosibirsk 630090, Russia
[2] Novosibirsk State Univ, Novosibirsk 630090, Russia
[3] RAS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia
基金
俄罗斯科学基金会;
关键词
Xenobiotics; NAT2; gene; NAT2*5; rs1801280; NAT2*7; rs1799931; Forest and Tundra Nenets; Northern Siberia; ARYLAMINE N-ACETYLTRANSFERASES; DRUG-METABOLIZING-ENZYMES; LUNG-CANCER; BLADDER-CANCER; RISK; N-ACETYLTRANSFERASE-2; GSTM1; SUSCEPTIBILITY; ACETYLATION; GENOTYPE;
D O I
10.1186/s12863-020-00909-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background N-acetyltransferase 2 plays a crucial role in the metabolism of a wide range of xenobiotics, including many drugs, carcinogens, and other chemicals in the human environment. The article presents for the first time data on the frequency of two important "slow" variants of NAT2 gene (NAT2*5, rs1801280 and NAT2*7, rs1799931), which significantly affect the rate of xenobiotics acetylation, among representatives of indigenous populations of Forest and Tundra Nenets in Northern Siberia. The aim of this study was to identify the frequencies of these variants and compare them with frequencies in other ethnic populations. Results NAT2*5 (T341C) genotyping revealed frequencies of 28,0% and 38,6% for Tundra and Forest Nenets, respectively. The frequencies of NAT2*7 (G857A) variant were 9,8% and 8,2% for Tundra and Forest Nenets, respectively. Polymorphic variants frequencies for Nenets are intermediate between those in populations of Europeans and Asians. These results can probably be explained by the presence of both European and Asian components in Nenets gene pools. Conclusions The results of this study expand the knowledge of NAT2 polymorphism in world populations. These data may also help assess the genetic predisposition of Nenets to multifactorial diseases associated with polymorphism in the NAT2 gene and, in general, contribute to the development of personalized medicine in reference to native people of Siberia.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population
    Salazar-Gonzalez, R.
    Gomez, R.
    Romano-Moreno, S.
    Medellin-Garibay, S.
    Nunez-Ruiz, A.
    Magana-Aquino, M.
    Milan-Segovia, R. C.
    Portales-Perez, D. P.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (12) : 7833 - 7843
  • [32] Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes
    Habil, Mariam R.
    Salazar-Gonzalez, Raul A.
    Doll, Mark A.
    Hein, David W.
    ARCHIVES OF TOXICOLOGY, 2022, 96 (11) : 2999 - 3012
  • [33] Caffeine as a metabolic probe: NAT2 phenotyping
    Notarianni, LJ
    Dobrocky, P
    Godlewski, G
    Jones, RW
    Bennett, PN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (03) : 169 - 173
  • [34] NAT2 Genotype and Isoniazid Medication in Children
    Golka, Klaus
    Selinski, Silvia
    EBIOMEDICINE, 2016, 11 : 11 - +
  • [35] Mesalazin pharmacokinetics and NAT2 activity.
    Lueck, H.
    Kinzig-Schippers, M.
    Jetter, A.
    Fuhr, U.
    Soergel, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S43 - S43
  • [36] N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice
    Loehle, Jennifer A.
    Cornish, Valerie
    Wakefield, Larissa
    Doll, Mark A.
    Neale, Jason R.
    Zang, Yu
    Sim, Edith
    Hein, David W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02): : 724 - 728
  • [37] Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population
    R. Salazar-González
    R. Gómez
    S. Romano-Moreno
    S. Medellín-Garibay
    A. Núñez-Ruíz
    M. Magaña-Aquino
    R. C. Milán-Segovia
    D. P. Portales-Pérez
    Molecular Biology Reports, 2014, 41 : 7833 - 7843
  • [38] Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes
    Mariam R. Habil
    Raúl A. Salazar-González
    Mark A. Doll
    David W. Hein
    Archives of Toxicology, 2022, 96 : 2999 - 3012
  • [39] Avoiding polymorphic metabolism of a series of new AMPA antagonists by NAT2
    Monostory, K
    Kohalmy, K
    Jemnitz, K
    Vereczkey, L
    Kobori, L
    DRUG METABOLISM REVIEWS, 2005, 37 : 59 - 60
  • [40] Allele-Specific Targeting and Haplotyping of the NAT2 Gene
    Papanikolaou, Georgia
    Wang, Wendy
    Boone, Erin
    Fakis, Giannoulis
    Boukouvala, Sotiria
    Gaedigk, Andrea
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 17 - 17